The Centre for Drug Research and Development (CDRD) and Todai TLO have inked an affiliation agreement to allow joint research projects.
The move is part of not-for profit CDRD’s plans to collaborate with a network of international affiliates representing the world’s top research institutions.
Through the deal Todai – a technology transfer organisation for the University of Tokyo who specialise in the transferring of intellectual assets from their research groups – hopes to advance its products into the commercial field.
President and CEO of Todai Takafumi Yamamoto said: “In general, most of the inventions disclosed at the University are pre-commercial technologies that require much further development.
“We believe that this affiliation agreement with CDRD will bring many benefits to the university and researchers to address this gap in the commercialisation path."